Daily Bulletin

Men's Weekly

.

Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

- Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire®

- 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after treatment

- 87.8% said they would recommend treatment to others with tinnitus

DUBLIN, June 30, 2022 /PRNe...

Read more: Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier...

Business News

Everything You Need to Know About Getting Support from Optus

Whether you've been an Optus customer for years or you've just switched over, at some point you'll probably need to contact their support team. Maybe your bill looks different from what you expected. ...

Daily Bulletin - avatar Daily Bulletin

The Marketing Strategy That’s Quietly Draining Sydney Business Owners’ Bank Accounts

Sydney businesses are investing more in digital marketing than ever before. The intention is clear. More visibility should mean more leads, more customers, and steady growth. However, many business ...

Daily Bulletin - avatar Daily Bulletin

Why Mining Hose Solutions Are Essential For High-Performance Industrial Operations

In environments where the ground itself is constantly shifting, breaking, and being reshaped, every component must be built to endure. Mining operations are among the most demanding in the industria...

Daily Bulletin - avatar Daily Bulletin